(NaturalNews) Google DeepMind CEO Demis Hassabis announced that AI-designed drugs from Isomorphic Labs, a Google spin-out, are expected to enter clinical…
AI-designed drugs set to enter clinical trials: A new era of health or a Trojan horse for corporate control?

Estimated read time
1 min read
You May Also Like
French Police Officers Terrorized In Series Of Brutal Attacks
September 18, 2025
Bipartisan Lawmakers Propose Federal Digital Identity Agency
September 18, 2025